298 related articles for article (PubMed ID: 32024826)
1. Liver governs adipose remodelling via extracellular vesicles in response to lipid overload.
Zhao Y; Zhao MF; Jiang S; Wu J; Liu J; Yuan XW; Shen D; Zhang JZ; Zhou N; He J; Fang L; Sun XT; Xue B; Li CJ
Nat Commun; 2020 Feb; 11(1):719. PubMed ID: 32024826
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditions.
Liu J; Jiang S; Zhao Y; Sun Q; Zhang J; Shen D; Wu J; Shen N; Fu X; Sun X; Yu D; Chen J; He J; Shi T; Ding Y; Fang L; Xue B; Li C
J Pathol; 2018 Nov; 246(3):277-288. PubMed ID: 29971772
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia/reperfusion injury.
Yang MQ; Du Q; Goswami J; Varley PR; Chen B; Wang RH; Morelli AE; Stolz DB; Billiar TR; Li J; Geller DA
Hepatology; 2018 Mar; 67(3):1056-1070. PubMed ID: 29059701
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling.
Corbit KC; Camporez JPG; Edmunds LR; Tran JL; Vera NB; Erion DM; Deo RC; Perry RJ; Shulman GI; Jurczak MJ; Weiss EJ
Diabetes; 2018 Feb; 67(2):208-221. PubMed ID: 29203511
[TBL] [Abstract][Full Text] [Related]
5. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.
McCullough RL; McMullen MR; Poulsen KL; Kim A; Medof ME; Nagy LE
Front Immunol; 2018; 9():2133. PubMed ID: 30294325
[No Abstract] [Full Text] [Related]
6. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
Zhang M; Sun W; Zhou M; Tang Y
Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
[TBL] [Abstract][Full Text] [Related]
7. Aerobic exercise training regulates serum extracellular vesicle miRNAs linked to obesity to promote their beneficial effects in mice.
de Mendonça M; Rocha KC; de Sousa É; Pereira BMV; Oyama LM; Rodrigues AC
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E579-E591. PubMed ID: 32744099
[TBL] [Abstract][Full Text] [Related]
8. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
10. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
11. Immune-Deficient Pfp/Rag2
Winkler S; Hempel M; Hsu MJ; Gericke M; Kühne H; Brückner S; Erler S; Burkhardt R; Christ B
Cells; 2019 Jul; 8(8):. PubMed ID: 31349725
[TBL] [Abstract][Full Text] [Related]
12. Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
Rodríguez A; Moreno NR; Balaguer I; Méndez-Giménez L; Becerril S; Catalán V; Gómez-Ambrosi J; Portincasa P; Calamita G; Soveral G; Malagón MM; Frühbeck G
Sci Rep; 2015 Jul; 5():12067. PubMed ID: 26159457
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.
Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ
Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119
[TBL] [Abstract][Full Text] [Related]
14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
15. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
16. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
[TBL] [Abstract][Full Text] [Related]
18. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
19. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
20. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
